These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 26669589)

  • 1. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
    Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L; Lu B; Yu J; Liu W; Zhou A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
    Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F; Ying H; He B; Pan Y; Sun H; Wang S
    Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
    Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM
    Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
    Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
    Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
    Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.
    Li L; Guo Z; Wang J; Mao Y; Gao Q
    Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma.
    El Mahdy HA; Abdelhamid IA; Amen AI; Abdelsameea E; Hassouna MM
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2723-2731. PubMed ID: 31554369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis.
    Guo X; Lv X; Lv X; Ma Y; Chen L; Chen Y
    Oncotarget; 2017 Jul; 8(27):44050-44058. PubMed ID: 28477010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.
    Sun Q; Li J; Jin B; Wang T; Gu J
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.